Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 30Unknown 24Recruiting 13Terminated 10Withdrawn 6Active not recruiting 6Not yet recruiting 5Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6

Conditions

Breast Neoplasms 6Esophageal Squamous Cell Carcinoma 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Neoplasm Metastasis 1Motor Activity 1Medulloblastoma 1Locally Advanced Rectal Carcinoma 1High-Risk Cancer 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Breast Cancer Metastatic 1Breast Cancer Invasive 1Adenocarcinoma Of Esophagus 1Adenocarcinoma 1

Interventions

Paclitaxel 62Letrozole 56Fulvestrant 54Trastuzumab 50palbociclib 42pembrolizumab 38Cyclophosphamide 37Carboplatin 37Anastrozole 37pertuzumab 35exemestane 25abemaciclib 24Tamoxifen 24Capecitabine 24ribociclib 22Radiotherapy 21Docetaxel 21olaparib 20Doxorubicin 20Magnetic Resonance Spectroscopy 19trastuzumab deruxtecan 17Surveys and Questionnaires 17Epirubicin 17durvalumab 16Specimen Handling 14Exercise 14130-nm albumin-bound paclitaxel 14Taxes 13Alpelisib 13Gonadotropin-Releasing Hormone 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Active not recruiting × Breast Neoplasms × Neoadjuvant Therapy × Clear all
NCT05296746 2026-05-14

RIBOLARIS

SOLTI Breast Cancer Research Group

Phase 2 Active not recruiting
1,100 enrolled
Breast

Breast Neoplasms

NCT02089100 2026-03-19

STEREO-SEIN

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Active not recruiting
154 enrolled
Breast

Breast Neoplasms

NCT07407244 2026-02-17

AKRA

Institute of Oncology Ljubljana

Phase NA Active not recruiting
268 enrolled
Breast

Breast Neoplasms

NCT05333874 2026-02-09

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

Rutgers, The State University of New Jersey

Phase EARLY_PHASE1 Active not recruiting
34 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00929214 2025-12-17

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
35 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT06190600 2025-04-30

SPORTNATHy

The Greater Poland Cancer Centre

Phase NA Active not recruiting
40 enrolled
Breast

Breast Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡